1. Home
  2. BNTC vs CVEO Comparison

BNTC vs CVEO Comparison

Compare BNTC & CVEO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • BNTC
  • CVEO
  • Stock Information
  • Founded
  • BNTC 1995
  • CVEO 1977
  • Country
  • BNTC United States
  • CVEO United States
  • Employees
  • BNTC N/A
  • CVEO N/A
  • Industry
  • BNTC Biotechnology: Pharmaceutical Preparations
  • CVEO Hotels/Resorts
  • Sector
  • BNTC Health Care
  • CVEO Consumer Discretionary
  • Exchange
  • BNTC Nasdaq
  • CVEO Nasdaq
  • Market Cap
  • BNTC 339.8M
  • CVEO 342.5M
  • IPO Year
  • BNTC N/A
  • CVEO N/A
  • Fundamental
  • Price
  • BNTC $13.43
  • CVEO $22.90
  • Analyst Decision
  • BNTC Strong Buy
  • CVEO Strong Buy
  • Analyst Count
  • BNTC 7
  • CVEO 1
  • Target Price
  • BNTC $24.43
  • CVEO $32.00
  • AVG Volume (30 Days)
  • BNTC 56.7K
  • CVEO 99.9K
  • Earning Date
  • BNTC 05-12-2025
  • CVEO 04-25-2025
  • Dividend Yield
  • BNTC N/A
  • CVEO 4.38%
  • EPS Growth
  • BNTC N/A
  • CVEO N/A
  • EPS
  • BNTC N/A
  • CVEO N/A
  • Revenue
  • BNTC N/A
  • CVEO $682,122,000.00
  • Revenue This Year
  • BNTC N/A
  • CVEO $7.59
  • Revenue Next Year
  • BNTC N/A
  • CVEO N/A
  • P/E Ratio
  • BNTC N/A
  • CVEO N/A
  • Revenue Growth
  • BNTC N/A
  • CVEO N/A
  • 52 Week Low
  • BNTC $4.75
  • CVEO $20.26
  • 52 Week High
  • BNTC $16.90
  • CVEO $28.92
  • Technical
  • Relative Strength Index (RSI)
  • BNTC 48.65
  • CVEO 52.84
  • Support Level
  • BNTC $12.98
  • CVEO $20.88
  • Resistance Level
  • BNTC $15.08
  • CVEO $22.65
  • Average True Range (ATR)
  • BNTC 1.16
  • CVEO 0.79
  • MACD
  • BNTC -0.24
  • CVEO 0.25
  • Stochastic Oscillator
  • BNTC 25.84
  • CVEO 72.30

About BNTC Benitec Biopharma Inc.

Benitec Biopharma Inc is a clinical-stage biotechnology company focused on the advancement of novel genetic medicines. Its technology has the potential to provide a one-shot cure for a wide range of diseases that are addressed by strict ongoing treatment regimens or that have no effective treatment or only palliative care options. The Company is developing a silence and replace-based therapeutic (BB-301) for the treatment of Oculopharyngeal Muscular Dystrophy (OPMD), a chronic, life threatening genetic disorder.

About CVEO Civeo Corporation (Canada)

Civeo Corp provides hospitality services to the natural resources industry in Canada, Australia and the United States. The company provides a full suite of services for guests, including lodging, catering and food service, housekeeping and maintenance at accommodation facilities that the company or its customers own. The company provides services that support the day-to-day operations of these facilities, such as laundry, facility management and maintenance, water and wastewater treatments, power generation, communication systems, security and logistics. The company operates in active oil, metallurgical coal, liquefied natural gas and iron ore-producing regions. The company operates in three reportable business segments Canada, Australia and the United States.

Share on Social Networks: